Royalty Pharma increases bid for drugmaker ElanNEW YORK -- Royalty Pharma is raising its offer to buy Elan on the condition that shareholders reject the Irish drugmaker's push to refocus its business through a string of recently announced deals.Royalty says it will pay $12.50 in cash for each ... Miami Herald, 7 hours ago |
See all (370) images for "elan" | ||||
Elan Corp (ELN) Plans Strategic Change of Company; Proposes $200M BuybackElan Corporation, plc (NYSE: ELN) (Elan) today announces a series of transactions designed to decisively transform and advance the company. Upon shareholder approval, the totality of these strategically driven decisions, in addition to the ... Street Insider, 15 hours ago
UPDATE 1-Elan strikes more deals to repel Royalty bid
CNBC, 16 hours ago
Elan announces two acquisitions
Irish Times, 17 hours ago
Elan strikes more deals, agrees second share buyback
Yahoo! UK and Ireland, 19 hours ago
|
Irish drugmaker Elan splurges $380 mn on two acquisitionsElan Corp, the Irish neuroscience-focused biotechnology company that is resisting a takeover bid from Royalty Pharma, has acquired two small rare disease drugmakers for $380 million. The Dublin-based company has acquired Vienna-based AOP Orphan ... Domain-B, 8 hours ago
Elan fends off takeover bid, plans acquisitions
MedCity News, 10 hours ago
Theravance Inc (THRX), GlaxoSmithKline plc (ADR) (GSK), Elan Corporation, plc (ADR) (ELN): Who Benefits From This Market Moving Biotechnology Partnership?
InsiderMonkey.com, 6 days ago
Elan launches US$1bn pharma royalty deal
TCE Today, 6 days ago
|
Elan Corporation plc to offer USD800.0m senior notes due 2021Biotechnology company Elan Corporation plc (NYSE:ELN) said on Monday that it plans to offer USD800.0m in aggregate principal amount of senior notes due 2021. This proposed offering, which is subject to market conditions, has been initiated by the ... Individual.com, 8 hours ago
Elan Acquires AOP Orphan for $340 Million as It Resists Bid
La Repubblica, 16 hours ago
Elan Makes Two Acquisitions for $380 Million as It Resists Bid
Washington Post, 17 hours ago
Elan To Offer $800 Mln Of Senior Notes Due 2021; Announces Several Transactions
RTTNews.com, 18 hours ago
|
Trading Higher on Heavy Volume are Shares of Elan on 3.7x Above-Average Volume (ELN)(Financial News Network On) Elan's stock is up 2.4% to $11.95 on heavy trading volume. About 23.9 million shares have been traded today, as compared to the 30-day average volume of 6.5 million shares. Unusually high volume can signify a potential ... Individual.com, 7 hours ago
Elan Shares Climbing Higher, Up 2.4%
Individual.com, 8 hours ago
Elan Trading Higher Today on Above-Average Volume, Consistent With Trend (ELN)
Comtex SmarTrend, 7 hours ago
Elan Shares Sinking Lower, Down 2.1%
Individual.com, 1 week ago
|
BRIEF-Elan asks shareholders not to take action on Royalty Pharma offer6:09pm BST LONDON, May 20 (Reuters) - Elan Corporation PLC : * Elan shareholders are strongly advised to take no action in relation to the royalty pharma offer * Source text Reuters UK, 8 hours ago
|
Elan Transformation Continues, but We Remain Skeptical of Deal ValuesMorningstar Canada, 9 hours ago |
REG-J.P. Morgan Securities plc. Form 38.5 - Elan Corporation plcForm 38.5 - Elan Corporation plc FORM 38.5 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 38.5 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2007 (AS AMENDED) DEALINGS BY CONNECTED EXEMPT MARKET-MAKERS 1. KEY INFORMATION 2. DEALINGS (Note 2) ... Reuters, 15 hours ago
Form 38.5 Elan Corporation Plc
TrustNet, 15 hours ago
ISE Only - REPLACEMENT - ELAN CORP PLC
TrustNet, 17 hours ago
Form 8.5 Elan Corporation Plc
TrustNet, 3 days ago
More from: , Morningstar UK...and 4 other sources
|
Form 6-K ELAN CORP PLC For: May 20BusinessWeek, 12 hours ago Form 6-K ELAN CORP PLC For: May 15 Street Insider, 5 days ago Form 6-K ELAN CORP PLC For: May 16 Street Insider, 3 days ago |
Elan to fund buying spree with USD800m high-yield bondLONDON, May 20 (IFR) - Irish drugmaker Elan will stage a return to the bond market this week with a USD800m high-yield offering that will fund share purchases, capital expenditure and acquisitions. The company, rated Ba3/B+, announced Morgan Stanley ... Reuters, 15 hours ago
US high-yield issuers rush to market
Yahoo! UK and Ireland, 9 hours ago
|